June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Expanding the phenotype of genetically associated electronegative ERG retinopathies: Comparing the full field ERG b:a ratio
Author Affiliations & Notes
  • Chris Ovens
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
  • Vannessa Leung
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
  • Elisa Eleanor Cornish
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
    Eye Genetics Research Unit, Children’s Medical Research Institute, The Children’s Hospital at Westmead, New South Wales, Australia
  • Dhimas Hari Sakti
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
    Eye Genetics Research Unit, Children’s Medical Research Institute, The Children’s Hospital at Westmead, New South Wales, Australia
  • Stephanie Retsas
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
  • Haipha Ali
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
  • Peter J McCluskey
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
  • Robyn V Jamieson
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
    Eye Genetics Research Unit, Children’s Medical Research Institute, The Children’s Hospital at Westmead, New South Wales, Australia
  • John R Grigg
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
    Eye Genetics Research Unit, Children’s Medical Research Institute, The Children’s Hospital at Westmead, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Chris Ovens None; Vannessa Leung None; Elisa Cornish None; Dhimas Hari Sakti None; Stephanie Retsas None; Haipha Ali None; Peter McCluskey None; Robyn Jamieson Belite Bio, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Belite Bio, Code R (Recipient), Novartis, Code R (Recipient); John Grigg Belite Bio, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Belite Bio, Code R (Recipient), Novartis, Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5215. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chris Ovens, Vannessa Leung, Elisa Eleanor Cornish, Dhimas Hari Sakti, Stephanie Retsas, Haipha Ali, Peter J McCluskey, Robyn V Jamieson, John R Grigg; Expanding the phenotype of genetically associated electronegative ERG retinopathies: Comparing the full field ERG b:a ratio. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5215.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : X-linked retinoschisis (RS1) and complete and incomplete congenital stationary night blindness (cCSNB, iCSNB) are inherited retinal dystrophies with a classically electronegative electroretinogram (ERG) defined as b:a ratio ≤1.0. Significant heterogeneity in ERG findings has been shown in these conditions, likely reflecting genotypic and thus mutation-target variation. Comparing these phenotypes through b:a ratio gives insights into genotype-phenotype correlations, questions current ERG diagnostic criteria and aids in localising pathology.

Methods : We conducted a retrospective analysis of ERG and genetic results in patients with a clinical diagnosis of iCSNB, cCSNB and RS1 at Save Sight Institute Sydney, Australia. Dark adapted (DA) 3.0 and DA 12.0 traces as per ISCEV standards were analysed and b:a ratios calculated. Mean b:a ratios were compared using 2-tailed unpaired student t-tests. An association between electropositive ERG and genetic diagnosis was assessed using chi-squared tests at b:a >1.0 and b:a >1.50 thresholds.

Results : 25 iCSNB, 13 cCSNB and 16 RS1 patients were included - 8 iCSNB, 2 cCSNB and 11 RS1 patients had genetic confirmation. Mean b:a ratios were equivalent for DA 3.0 and DA 12.0 ERGs. Genetically proven iCSNB cases had lower mean b:a compared to the overall iCSNB cohort (0.62 vs 0.80, p = 0.0008), while there was no difference for cCSNB or RS1. In genetically proven patients, mean b:a ratios in cCSNB (0.52) was significantly lower than iCSNB (0.62, p=0.042) and RS1 (1.04, p<0.0001), and iCSNB was significantly lower than RS1 (p<0.0001). The proportion of patients with b:a >1.0 was iCSNB 1/8, cCSNB 0/2 and RS1 7/11, while 0/8 iCSNB, 0/2 cCSNB and 2/11 RS1 patients had b:a >1.50. An electropositive ERG was significantly more likely to be associated with RS1 than iCSNB (p=0.026) at b:a >1.0 threshold.

Conclusions : These findings highlight the expanded variability in b:a ratios. A diagnosis of a classical electronegative inner retinal dystrophy should include ratios up to at least 1.5. RS1 patients were frequently found to be electropositive whilst a b:a ratio of > 1.50 did not encompass any CSNB cases. No cCSNB case had a ratio >1.0. The variation in ERG b:a ratio between the groups further assists in guiding genetic testing and their interpretation.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×